Discordant Association of C-Reactive Protein With Clinical Events and Coronary Luminal Narrowing in Postmenopausal Women: Data From the Women's Angiographic Vitamin and Estrogen (WAVE) Study

被引:3
作者
Patel, Dhavalkumar [1 ,2 ]
Jhamnani, Sunny [1 ]
Ahmad, Soha [3 ]
Silverman, Angela [4 ]
Lindsay, Joseph [3 ]
机构
[1] Washington Hosp Ctr, Dept Internal Med, Washington, DC 20010 USA
[2] Virginia Commonwealth Univ Hosp, Div Cardiol, Dept Internal Med, Richmond, VA USA
[3] Washington Hosp Ctr, Dept Cardiol, Washington, DC 20010 USA
[4] MedStar Res Inst, Hyattsville, MD USA
关键词
DENSITY-LIPOPROTEIN CHOLESTEROL; ARTERY-DISEASE; CAROTID ATHEROSCLEROSIS; ENDOTHELIAL FUNCTION; PLAQUE PROGRESSION; HEART-DISEASE; INFLAMMATION; RISK; RESTENOSIS; PREDICTION;
D O I
10.1002/clc.22155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The incidence of cardiovascular events had been shown to be associated with C-reactive protein (CRP). However, it is unclear that the cardiovascular risk associated with CRP is due to progressive coronary narrowing or to other factors such as formation of unstable plaque. This study was designed to determine the effect of baseline CRP on cardiovascular events and on the progression of atherosclerotic narrowing among 423 postmenopausal women with angiographic stenosis between 15% and 75%. Hypothesis: Baseline CRP levels may affect cardiovascular events and progression of atherosclerotic coronary artery narrowing among postmenopausal women. Methods: Baseline and follow-up (2.8 years) angiographic data were analyzed among 320 women. Women were stratified into 4 quartiles according to baseline CRP levels. The changes in lumen diameter and clinical events in each quartile were compared. Results: The annualized changes in minimal and average lumen diameter in diseased and nondiseased coronary segments were not significantly associated with baseline CRP levels. The composite end point of all-cause mortality and myocardial infarction (MI) increased from 3% (3/107) in the first CRP quartile to 14% (14/98) in fourth CRP quartile (P < 0.001). Similar results were found for cardiovascular death and MI (increased from 1% (2/107) in the first quartile to 11% (11/98) in fourth quartile). The difference remained significant even after adjustment for baseline differences and cardiovascular risk factors. Conclusions: Higher baseline CRP was associated with increased risk of clinical events but was not associated with annualized change in luminal diameters. Thus, increased risk of adverse events among patients with higher baseline CRP events was independent of progression of atherosclerosis as measured by change in minimal or average luminal diameter.
引用
收藏
页码:535 / 541
页数:7
相关论文
共 36 条
[1]   C-reactive protein elevation and disease activity in patients with coronary artery disease [J].
Arroyo-Espliguero, R ;
Avanzas, P ;
Cosín-Sales, J ;
Aldama, G ;
Pizzi, C ;
Kaski, JC .
EUROPEAN HEART JOURNAL, 2004, 25 (05) :401-408
[2]   Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol [J].
Bayturan, Ozgur ;
Kapadia, Samir ;
Nicholls, Stephen J. ;
Tuzcu, E. Murat ;
Shao, Mingyuan ;
Uno, Kiyoko ;
Shreevatsa, Ajai ;
Lavoie, Andrea J. ;
Wolski, Kathy ;
Schoenhagen, Paul ;
Nissen, Steven E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (24) :2736-2736
[3]   Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects [J].
Bisoendial, Radjesh J. ;
Kastelein, John J. P. ;
Peters, Stephan L. M. ;
Levels, Johannes H. M. ;
Birjmohun, Rakesh ;
Rotmans, Joris I. ;
Hartman, Daniel ;
Meijers, Joost C. M. ;
Levi, Marcel ;
Stroes, Erik S. G. .
JOURNAL OF LIPID RESEARCH, 2007, 48 (04) :952-960
[4]   C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the US Preventive Services Task Force [J].
Buckley, David I. ;
Fu, Rongwei ;
Freeman, Michele ;
Rogers, Kevin ;
Helfand, Mark .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (07) :483-W161
[5]   Elevated C-reactive protein values and atherosclerosis in sudden coronary death - Association with different pathologies [J].
Burke, AP ;
Tracy, RP ;
Kolodgie, F ;
Malcom, GT ;
Zieske, A ;
Kutys, R ;
Pestaner, J ;
Smialek, J ;
Virmani, R .
CIRCULATION, 2002, 105 (17) :2019-2023
[6]  
Burke AP, 2001, CIRCULATION, V103, P934
[7]   Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease [J].
Elliott, Paul ;
Chambers, John C. ;
Zhang, Weihua ;
Clarke, Robert ;
Hopewell, Jemma C. ;
Peden, John F. ;
Erdmann, Jeanette ;
Braund, Peter ;
Engert, James C. ;
Bennett, Derrick ;
Coin, Lachlan ;
Ashby, Deborah ;
Tzoulaki, Ioanna ;
Brown, Ian J. ;
Mt-Isa, Shahrul ;
McCarthy, Mark I. ;
Peltonen, Leena ;
Freimer, Nelson B. ;
Farrall, Martin ;
Ruokonen, Aimo ;
Hamsten, Anders ;
Lim, Noha ;
Froguel, Philippe ;
Waterworth, Dawn M. ;
Vollenweider, Peter ;
Waeber, Gerard ;
Jarvelin, Marjo-Riitta ;
Mooser, Vincent ;
Scott, James ;
Hall, Alistair S. ;
Schunkert, Heribert ;
Anand, Sonia S. ;
Collins, Rory ;
Samani, Nilesh J. ;
Watkins, Hugh ;
Kooner, Jaspal S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (01) :37-48
[8]   CORONARY PLAQUE DISRUPTION [J].
FALK, E ;
SHAH, PK ;
FUSTER, V .
CIRCULATION, 1995, 92 (03) :657-671
[9]   SMOOTH-MUSCLE CELL ABUNDANCE AND FIBROBLAST GROWTH-FACTORS IN CORONARY LESIONS OF PATIENTS WITH NONFATAL UNSTABLE ANGINA - A CLUE TO THE MECHANISM OF TRANSFORMATION FROM THE STABLE TO THE UNSTABLE CLINICAL STATE [J].
FLUGELMAN, MY ;
VIRMANI, R ;
CORREA, R ;
YU, ZX ;
FARB, A ;
LEON, MB ;
ELAMI, A ;
FU, YM ;
CASSCELLS, W ;
EPSTEIN, SE .
CIRCULATION, 1993, 88 (06) :2493-2500
[10]   C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study [J].
Grammer, Tanja B. ;
Maerz, Winfried ;
Renner, Wilfried ;
Boehm, Bernhard O. ;
Hoffmann, Michael M. .
EUROPEAN HEART JOURNAL, 2009, 30 (02) :170-182